AMBROGAL 20mg pills medication leaflet

R02AD ambroxol • Respiratory system | Throat preparations | Anesthetics, local

Ambroxol is a mucolytic agent used to treat respiratory conditions characterized by excessive production of viscous mucus. It is indicated for acute and chronic bronchitis, asthma, chronic obstructive pulmonary disease (COPD), and other lung conditions involving difficulty in mucus clearance.

Ambroxol works by reducing mucus viscosity and stimulating the activity of cilia in the airways, facilitating expectoration. It is effective in relieving productive cough and improving breathing.

Additionally, ambroxol has anti-inflammatory and antioxidant properties, making it useful in reducing airway inflammation. In some cases, it is also used to alleviate sore throat pain due to its local anesthetic effect.

It is available in the form of tablets, syrup, oral solution, or inhalation, and is well-tolerated by most patients. Side effects are rare and may include nausea, stomach discomfort, or mild allergic reactions.

General data about AMBROGAL 20mg

Substance: ambroxol

Commercial code: W69738001

Concentration: 20mg

Pharmaceutical form: pills

Product type: generic

Prescription restrictions: OTC - Over the Counter = medicines that do not require a prescription.

Marketing authorisation

Manufacturer: NETPHARMALAB CONSULTING SERVICES - SPANIA

Holder: GALENIKA INTERNATIONAL KFT. - UNGARIA

Number: 15106/2023/01

Shelf life: 2 years

Concentrations available for ambroxol

0.3%, 0.75%, 15mg, 15mg/5ml, 15mg/ml, 20mg, 30mg, 30mg/5ml, 3mg/ml, 50mg/g, 60mg, 6mg/ml, 7.5mg/ml, 75mg

Other substances similar to ambroxol